Overview

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of etanercept on the clinical benefit, safety, and physical functioning (ability to function in daily life) in children and adolescent subjects with 3 subtypes of childhood arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Etanercept